NeoGenesis Korea

NeoGenesis was founded in 2012 and has been dedicated to researching and developing innovative medical devices. With expertise in the field of autologous cell therapy, we provide medical devices not only to the domestic market but also to the global market, including the Americas, Europe, Asia, and Africa.

We actively share our knowledge of modern cell therapy by participating in seminars, exhibitions, and training sessions worldwide, contributing to the advancement of the global industry. NeoGenesis is committed to delivering safe and high-quality medical devices and pharmaceuticals, striving to ensure the convenience, satisfaction, and trust that our patients rightfully deserve.